News

Growing Applications of Analytical Techniques in Proteomics and Metabolomics

by

DUBLIN, Dec. 29, 2023 /PRNewswire/ — The “Global Analytical Standards Market by Category (Organic, Inorganic), Technique (GC, MS, LC, IR, NMR, Gravimetry), Method (Bioanalytical, Dissolution, Material Testing), Application (Food, Environmental, Pharmaceutical, Forensics) and Region – Forecast to 2028” report has been added to  ResearchAndMarkets.com’s offering. The global analytical standards market is projected to reach USD … Read more

Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic’s Proposed Merger with Standard BioTools

by

BOULDER, Colo., Dec. 28, 2023 /PRNewswire/ — Dr. Larry Gold, the founder of SomaLogic, Inc. (“SomaLogic” or the “Company”) (Nasdaq: SLGC) and Dr. Jason Cleveland, SomaLogic’s current Chief Technology Officer, are issuing the below letter to SomaLogic’s stockholders regarding their opposition to the Company’s proposed merger with Standard BioTools, Inc. (“Standard”) (Nasdaq: LAB).  Dear Fellow … Read more

Law Offices of Jason Turchin Expands National Product Liability Division to Combat a Wide Range of Defective Products

by

FORT LAUDERDALE, Fla., Dec. 27, 2023 /PRNewswire/ — The Law Offices of Jason Turchin is proud to announce the expansion of its National Product Liability division, now extensively covering a multitude of sectors affected by defective products. This expansion is a testament to the firm’s commitment to consumer safety and accountability in manufacturing. Consumer ProductsOur enhanced … Read more

Senhwa Biosciences Received Taiwan FDA IND Approval for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia (CAP) Associated with Viral Infection

by

TAIPEI and SAN DIEGO, Dec. 26, 2023 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, announced today that Taiwan Food and Drug Administration has approved its Phase II IND application of Silmitasertib (CX-4945) to treat patients with community-acquired pneumonia (CAP) caused … Read more

GenSci lance un centre mondial d’innovation à Shanghai

by

La création de ce centre démontre l’engagement de l’entreprise à fournir des solutions adaptées aux défis de la gynécologie et de la pédiatrie SHANGHAI, 25 décembre 2023 /PRNewswire/ — Changchun GeneScience Pharmaceutical (« GenSci »), une filiale de Changchun High-Tech Industries (Group), a organisé le 15 décembre une cérémonie de pose de la première pierre de son nouveau … Read more

Home for the Holidays — DispatchHealth Delivers Emergency Room Magic to Your Living Room

by

DENVER, Dec. 24, 2023 /PRNewswire/ — As the holiday season brings joy and festivities, it also comes with its share of health concerns for many community members. Traditionally, emergency rooms (ER) have been the go-to destination for holiday health mishaps; however, DispatchHealth offers another option for urgent medical care—one that delivers healthcare right to patients’ … Read more

Uno de cada cinco adultos carece de la capacidad de aislar a un familiar enfermo durante un brote epidémico

by

Encuesta de Heluna Health identifica una serie de deficiencias en el conocimiento y las barreras socio económicas que dificultan la preparación ante brotes epidémicos LOS ÁNGELES, 23 de diciembre de 2023 /PRNewswire-HISPANIC PR WIRE/ — Una quinta parte de los adultos estadounidenses afirma que no estarían en condiciones de aislar a un miembro enfermo de … Read more

GenSci Launches Global Innovation Hub in Shanghai

by

The Establishment of the Facility Demonstrates the Company’s Commitment to Delivering Differentiated Solutions to Gynecology and Pediatrics Challenges SHANGHAI, Dec. 22, 2023 /PRNewswire/ — Changchun GeneScience Pharmaceutical (“GenSci”), a subsidiary of Changchun High-Tech Industries (Group), held a groundbreaking ceremony for its new global headquarters and research & development (R&D) center at Shanghai Zhangjiang International Medical … Read more

Know Your Lemons® Foundation acquires Dr. Susan Love Foundation for Breast Cancer Research ImPatient Science® Video Series for Breast Cancer Patients

by

LOS ANGELES, Dec. 22, 2023 /PRNewswire/ — The groundbreaking ImPatient Science video series created for breast cancer patients, their families, caregivers, and friends to better understand the disease and choices in care is now part of the Know Your Lemons foundation, dedicated to early detection and breast cancer education. The digital series includes 60 videos, each breaking … Read more